• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer.淋巴结清扫范围与围手术期治疗:胃癌的两个未解决问题。
World J Gastroenterol. 2014 Apr 14;20(14):3889-904. doi: 10.3748/wjg.v20.i14.3889.
2
Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.比较腹腔镜远端胃癌切除术(D2淋巴结清扫术加完整胃系膜切除术,D2+CME)与传统D2淋巴结清扫术治疗局部进展期胃腺癌的前瞻性随机对照试验:一项随机对照试验的研究方案
Trials. 2018 Aug 9;19(1):432. doi: 10.1186/s13063-018-2790-5.
3
Resection for gastric cancer in the community.社区胃癌切除术
Semin Oncol. 2005 Dec;32(6 Suppl 9):S90-3. doi: 10.1053/j.seminoncol.2005.06.010.
4
Radiotherapy in gastric cancer: a systematic review of literature and new perspectives.胃癌的放射治疗:文献系统综述及新观点
Expert Rev Anticancer Ther. 2007 Oct;7(10):1379-93. doi: 10.1586/14737140.7.10.1379.
5
Predictors of survival outcome following radical gastrectomy for gastric cancer.胃癌根治性切除术后生存结局的预测因素。
ANZ J Surg. 2019 Jan;89(1-2):84-89. doi: 10.1111/ans.15011. Epub 2019 Jan 28.
6
A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.原发性胃癌切除术后辅助治疗的综述及大邱腹腔化疗Ⅲ期试验的最新进展。
Eur J Surg Oncol. 2006 Aug;32(6):655-60. doi: 10.1016/j.ejso.2006.03.010. Epub 2006 Apr 18.
7
Optimal locoregional treatment in gastric cancer.胃癌的最佳局部区域治疗
J Clin Oncol. 2005 Jul 10;23(20):4509-17. doi: 10.1200/JCO.2005.21.196.
8
Lymphadenectomy for gastric cancer: still a matter of debate?胃癌淋巴结清扫术:仍是一个有争议的问题?
Ann Ital Chir. 2012 May-Jun;83(3):199-207.
9
GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study.胃切除和腹腔内热灌注化疗治疗局部进展期胃癌:一项随机多中心 III 期研究。
BMC Cancer. 2014 Mar 14;14:183. doi: 10.1186/1471-2407-14-183.
10
Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis?对于存在第 6 组淋巴结转移的远端胃癌,行标准 D2 胃切除术时是否值得附加肠系膜上静脉淋巴结(14v)清扫?
Clin Transl Oncol. 2019 Dec;21(12):1699-1706. doi: 10.1007/s12094-019-02103-0. Epub 2019 Apr 11.

引用本文的文献

1
Tracers in Gastric Cancer Surgery.胃癌手术中的示踪剂
Cancers (Basel). 2022 Nov 22;14(23):5735. doi: 10.3390/cancers14235735.
2
Lymph Node Mapping in Gastric Cancer Surgery: Current Status and New Horizons.胃癌手术中的淋巴结图谱:现状与新视野
Turk J Surg. 2020 Dec 8;36(4):393-398. doi: 10.47717/turkjsurg.2020.4932. eCollection 2020 Dec.
3
Comparison of Treatment Modalities for Locally Advanced Gastric Cancer: A Propensity Score Matching Analysis.局部进展期胃癌治疗方式的比较:一项倾向评分匹配分析
J Cancer. 2020 May 18;11(15):4421-4430. doi: 10.7150/jca.41082. eCollection 2020.
4
Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?胃癌的新辅助化疗:是必须,还是噱头?
World J Gastroenterol. 2018 Jan 14;24(2):274-289. doi: 10.3748/wjg.v24.i2.274.
5
Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis.基于人群的分析验证美国癌症联合委员会(AJCC)第 8 版胃癌分期系统。
Gastric Cancer. 2018 May;21(3):391-400. doi: 10.1007/s10120-017-0770-1. Epub 2017 Oct 20.
6
Near-infrared fluorescence sentinel lymph node detection in gastric cancer: A pilot study.胃癌中近红外荧光前哨淋巴结检测:一项初步研究。
World J Gastroenterol. 2016 Apr 7;22(13):3644-51. doi: 10.3748/wjg.v22.i13.3644.
7
Gastric cancer: Current status of lymph node dissection.胃癌:淋巴结清扫的现状
World J Gastroenterol. 2016 Mar 14;22(10):2875-93. doi: 10.3748/wjg.v22.i10.2875.
8
Surgical interventions for gastric cancer: a review of systematic reviews.胃癌的外科干预:系统评价综述
Int J Clin Exp Med. 2015 Aug 15;8(8):13657-69. eCollection 2015.
9
Extent of lymph node dissection for adenocarcinoma of the stomach.胃癌腺癌的淋巴结清扫范围。
Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD001964. doi: 10.1002/14651858.CD001964.pub4.
10
Review on the Applications and Molecular Mechanisms of Xihuang Pill in Tumor Treatment.西黄丸在肿瘤治疗中的应用及分子机制综述
Evid Based Complement Alternat Med. 2015;2015:854307. doi: 10.1155/2015/854307. Epub 2015 Jun 10.

本文引用的文献

1
Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.胃癌临床实践指南(2013 年版):NCCN 指南的重点更新内容。
J Natl Compr Canc Netw. 2013 May 1;11(5):531-46. doi: 10.6004/jnccn.2013.0070.
2
How many lymph nodes should be assessed in patients with gastric cancer? A systematic review.胃癌患者应该评估多少个淋巴结?系统综述。
Gastric Cancer. 2012 Sep;15 Suppl 1:S70-88. doi: 10.1007/s10120-012-0169-y. Epub 2012 Aug 16.
3
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.SWOG 指导的分组研究 0116 的更新分析:辅助放化疗与根治性胃癌切除术后观察的 III 期临床试验。
J Clin Oncol. 2012 Jul 1;30(19):2327-33. doi: 10.1200/JCO.2011.36.7136. Epub 2012 May 14.
4
Treatment of resectable gastric cancer.可切除胃癌的治疗。
Therap Adv Gastroenterol. 2012 Jan;5(1):49-69. doi: 10.1177/1756283X11410771.
5
WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.撤回:胃癌腺癌扩大与有限淋巴结清扫技术对比
Cochrane Database Syst Rev. 2012 Jan 18;1:CD001964. doi: 10.1002/14651858.CD001964.pub3.
6
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.卡培他滨和奥沙利铂辅助治疗 D2 胃切除术后胃癌(CLASSIC):一项开放标签、随机对照 3 期临床试验。
Lancet. 2012 Jan 28;379(9813):315-21. doi: 10.1016/S0140-6736(11)61873-4. Epub 2012 Jan 7.
7
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.III 期临床试验比较卡培他滨联合顺铂与卡培他滨联合顺铂同步卡培他滨放疗在完全切除胃腺癌且行 D2 淋巴结清扫术后的疗效:ARTIST 试验。
J Clin Oncol. 2012 Jan 20;30(3):268-73. doi: 10.1200/JCO.2011.39.1953. Epub 2011 Dec 19.
8
A meta-analysis of D1 versus D2 lymph node dissection.D1 与 D2 淋巴结清扫术的荟萃分析。
Gastric Cancer. 2012 Sep;15 Suppl 1:S60-9. doi: 10.1007/s10120-011-0110-9. Epub 2011 Dec 3.
9
Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.一项比较辅助化疗 S-1 与单纯手术治疗 II 期或 III 期胃癌的随机 III 期临床试验的 5 年结果。
J Clin Oncol. 2011 Nov 20;29(33):4387-93. doi: 10.1200/JCO.2011.36.5908. Epub 2011 Oct 17.
10
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).可切除胃癌患者新辅助化疗后手术及化疗或手术及放化疗(CRITICS)。
BMC Cancer. 2011 Aug 2;11:329. doi: 10.1186/1471-2407-11-329.

淋巴结清扫范围与围手术期治疗:胃癌的两个未解决问题。

Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer.

作者信息

Giuliani Andrea, Miccini Michelangelo, Basso Luigi

机构信息

Andrea Giuliani, Michelangelo Miccini, Luigi Basso, Department of Surgery "Pietro Valdoni", "Sapienza" University of Rome, Medical School, Policlinico "Umberto I", 00161 Rome, Italy.

出版信息

World J Gastroenterol. 2014 Apr 14;20(14):3889-904. doi: 10.3748/wjg.v20.i14.3889.

DOI:10.3748/wjg.v20.i14.3889
PMID:24744579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3983445/
Abstract

Gastric cancer is one of the leading causes of death for cancer worldwide, although geographical variations in incidence exist. Over the last decades, its incidence and mortality have gradually decreased in Western countries, while these have increased, or remained stable, in the other world regions. Gastric cancer is often diagnosed at an advanced stage, with the only notable exception of Japan, where nationwide screening programs are enforced, due to local high incidence. Curative- intent surgery (i.e., gastrectomy, total or partial, and lymphadenectomy) remains the cornerstone of treatment of gastric cancer. Much has been debated about the extent of lymph node dissection and, although it is a valuable contribution to staging and cure, operative treatment only represents one aspect of overall effective management, as the risk of both locoregional and distant recurrences are high, and bear a poor prognosis. As a matter of fact, surgery, as a single modality treatment, has probably achieved its maximum efficacy for local control and survival, while other accompanying nonsurgical treatment modalities have to be taken into account, although their role is still the subject of considerable debate. The authors in this review present an update on the outcome of treatment of gastric cancer in relation to the extent of lymphadenectomy and of various nonsurgical preoperative, intraoperative, and postoperative strategies.

摘要

胃癌是全球癌症死亡的主要原因之一,尽管其发病率存在地域差异。在过去几十年中,西方国家的胃癌发病率和死亡率逐渐下降,而在世界其他地区,发病率则有所上升或保持稳定。胃癌通常在晚期才被诊断出来,唯一显著的例外是日本,由于当地发病率高,日本实施了全国性的筛查计划。根治性手术(即全胃或部分胃切除术以及淋巴结清扫术)仍然是胃癌治疗的基石。关于淋巴结清扫范围的争论很多,尽管它对分期和治愈有重要贡献,但手术治疗只是整体有效管理的一个方面,因为局部和远处复发的风险都很高,预后较差。事实上,作为单一治疗方式的手术,在局部控制和生存方面可能已经达到了最大疗效,尽管其他非手术治疗方式的作用仍存在很大争议,但仍需考虑。本综述的作者介绍了与淋巴结清扫范围以及各种非手术术前、术中和术后策略相关的胃癌治疗结果的最新情况。